Cystine
Small molecule in Homo sapiens that 1 drug acts on.
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Cysteamine | Approved | Leadiant Biosciences | Small molecule | Reducing agentCystine reducing agent | 7 |
| Pilot Study of TTI-0102 in Cystinosis | Cysteamine | Phase 2 | Not yet recruiting | Thiogenesis Therapeutics, Inc. | Sep 23, 2026 |
| European Cystinosis Cohort 2 | Cysteamine | — | Not yet recruiting | Institut National de la Santé Et de la Recherche Médicale, France | Jul 2, 2026 |
| Cystinosis and Mitochondrial Metabolism | Cysteamine | Not applicable | Recruiting | Hospices Civils de Lyon | Jan 6, 2026 |
| A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) | Cysteamine | Phase 2 | Not yet recruiting | Thiogenesis Therapeutics, Inc. | May 25, 2025 |
| DFT383 in Pediatric Participants With Nephropathic Cystinosis | Cysteamine | Phase 1 / Phase 2 | Recruiting | Novartis Pharmaceuticals | Apr 4, 2025 |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | Cysteamine | Phase 3 | Recruiting | UMC Utrecht | Apr 13, 2016 |
| Use of Cysteamine in the Treatment of Cystinosis | Cysteamine | — | Recruiting | National Human Genome Research Institute (NHGRI) | Aug 2, 2006 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364039, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets